Before the Bowl: A UK Guide to CBD Claims for Dogs and Cats

CBD for pets has moved from the margins of online forums into mainstream UK retail conversation. Owners understandably ask whether cannabidiol might help a dog unsettled by fireworks, a cat struggling with travel, or an older animal whose joints seem stiffer than they used to. The question is reasonable. The answer, however, is not a simple matter of buying a bottle and adjusting the dose.

At Cannabi CBD we normally write about human CBD wellness, dosage and consumer protection. Pets deserve the same calm scrutiny, but they do not sit in the same category. A dog or cat is not a small person, and a product sold for human use is not a convenient shortcut. The legal framework is different, the clinical evidence is thinner, and the marketing can be considerably less careful than the subject warrants.

Why pet CBD is a different category

For people, CBD is generally treated as a novel food or a consumer product, with rules around labelling, THC content and permitted claims. For animals, the starting point is veterinary medicines law. A product intended to treat, prevent or diagnose disease in an animal, or to alter an animal’s physiology, may fall within the Veterinary Medicines Regulations. That is a regulatory line, not a marketing preference.

As of 2026, readers should check the Veterinary Medicines Directorate register for themselves, but no CBD product is authorised as a veterinary medicine in the UK for dogs or cats. That matters. It means claims that a product treats anxiety, pain, epilepsy or arthritis in pets are not ordinary wellness language. They are medicinal claims, and they require authorisation.

A vet may, in limited circumstances, prescribe an authorised medicine off-label where no suitable authorised product exists. That is a clinical decision made within the veterinary cascade, with the animal’s interests and the available evidence in view. It is not a loophole that allows owners to improvise with human CBD products at home.

The human-product shortcut is not a sensible one

It is easy to see why owners try. A bottle of CBD oil is already in the cupboard; the internet offers weight-based charts; the language of ‘full spectrum’ and ‘gentle support’ sounds reassuring. But human products are formulated for human use. They may contain carrier oils, flavourings, sweeteners or preservatives that are unsuitable for animals. They may contain THC at a level tolerated by adult humans but risky for a pet. They may be inconsistent from batch to batch.

Dogs and cats also handle compounds differently. Cats in particular are less able to process many substances, and their grooming habits can lead to repeated low-level exposure. A product that seems mild to a person can produce gastrointestinal upset, lethargy or worse in a smaller animal. Interactions with existing medication are another unknown. The honest position is that the dose, safety profile and long-term effects of CBD in companion animals are not established well enough for casual experimentation.

What retailers can and cannot imply

UK retailers should not imply that a pet product prevents, treats or cures a condition unless it is authorised to do so. Phrases such as ‘vet-approved’, ‘clinically proven’ or ‘natural anxiety relief’ deserve scrutiny. A testimonial from an owner is not evidence of efficacy. A weight chart on a listing is not a dosing instruction. ‘THC-free’ is not meaningful without a batch-specific certificate of analysis, and even that should be read with care.

Red flags include products sold with confident disease claims, vague assurances that they are ‘safe for all pets’, multi-ingredient formulations that mix CBD with herbs or essential oils, and retailers who discourage a veterinary conversation. Owners can ask for the manufacturer’s name, the batch certificate, the THC result, the expiry date and any VMD authorisation number. If a seller cannot answer basic questions, that is useful consumer information in itself.

Misleading medicinal claims can be reported to the Veterinary Medicines Directorate, the Advertising Standards Authority or Trading Standards. That route exists because animal medicines are not a corner of the market where optimism should substitute for evidence.

Questions to ask your vet

Before buying anything, speak to your vet. The first question is not ‘what dose?’ but ‘what are we treating?’ A diagnosis or at least a clear description of the problem changes the conversation. Ask whether CBD is appropriate at all, what evidence exists for the species and condition, and what alternatives are better established. Ask about interactions with current medicines and about signs that would mean stopping and seeking help.

If a vet does consider a CBD product, ask who is supplying it, how it is formulated, what dose is being proposed and how the animal will be monitored. Ask what adverse effects to watch for and when to call the practice. Do not stop prescribed medication without veterinary advice. If a pet eats a human CBD edible or oil accidentally, treat it as a potential poisoning and contact the vet promptly.

The practical unknowns

There is no established UK dosing schedule for CBD in dogs or cats that an owner can safely apply at home. ‘Start low and go slow’ is a human harm-reduction heuristic, not a veterinary prescription. Bioavailability varies by product and species. Long-term safety data are limited. Product quality varies. These are not reasons to panic; they are reasons to be slow, conservative and guided by a professional.

The calm conclusion is straightforward. CBD for pets may be an area of legitimate veterinary interest, but it is not a consumer free-for-all. The label on a bottle is not a licence to treat an animal. The lead, the bowl and the vet’s advice should come before the label.